Evidence map›Paper›PMID 22560220›Full record

ArticleCell metabolism2012

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function.

Nathan L Price, Ana P Gomes, Alvin J Y Ling, Filipe V Duarte, Alejandro Martin-Montalvo, Brian J North, Beamon Agarwal, Lan Ye, Giorgio Ramadori, Joao S Teodoro and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 858 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
858citing papers in PubMed, 5 pooled it
59.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

858 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,538 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Resveratrol and Female Fertility: A Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  6. Review
  7. Review
  8. O-methylation of phenolic natural products: translational insights from resveratrol.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Aging and cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  20. Article

798 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 4 countries.

Nathan L PriceGlenn Laboratories for the Biological Mechanisms of Aging, Harvard Medical School, Boston, MA 02115, USA.
Ana P Gomes
Alvin J Y Ling
Filipe V Duarte
Alejandro Martin-Montalvo
Brian J North
Beamon Agarwal
Lan Ye
Giorgio Ramadori
Joao S Teodoro
Basil P Hubbard
Ana T Varela
James G Davis
Behzad Varamini
Angela Hafner
Ruin Moaddel
Anabela P Rolo
Roberto Coppari
Carlos M Palmeira
Rafael de Cabo
Joseph A Baur
David A Sinclair
Harvard University · USUniversity of Pennsylvania · USNational Institutes of Health · USMarche Polytechnic University · ITNational Institute on Aging · USThe University of Texas Southwestern Medical Center · USUniversity of Aveiro · PTUniversity of Coimbra · PT

Funding

Aging Intervention ProgramZIAAG000363 · NIA · NATIONAL INSTITUTE ON AGING · PI DE CABO, RAFAEL · 2009 to 2025
$9.0M
THE ROLE OF Cdk5 IN THE DNA DAMAGE RESPONCE DURING AGING AND NEURODEGENERATIONP01AG027916 · NIA · HARVARD MEDICAL SCHOOL · PI YUAN, JUNYING · 2006 to 2010
$7.7M
Role of Sgs1 DNA helicase in telomere maintenanceR01AG019719 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SINCLAIR, DAVID A. · 2001 to 2022
$5.3M
NRF2 interactions with SIRT1 and its role on caloric restrictionZIAAG000361 · NIA · NATIONAL INSTITUTE ON AGING · PI DE CABO, RAFAEL · 2009 to 2024
$5.3M
SIRT1 as a regulator of health and lifespan of mammalsR37AG028730 · NIA · HARVARD MEDICAL SCHOOL · PI SINCLAIR, DAVID A. · 2012 to 2021
$4.1M
SIRT as a regulator of health and lifespan of mammalsR01AG028730 · NIA · HARVARD MEDICAL SCHOOL · PI SINCLAIR, DAVID A. · 2007 to 2011
$1.7M
The Physiological Relevance of SIRT1 in Brain on Energy and Glucose HomeostasisR01DK080836 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI COPPARI, ROBERTO · 2009 to 2012
$1.5M
NIA NIH HHS P01 AG027916NIA NIH HHS R01 AG019719NIA NIH HHS R01 AG028730NIA NIH HHS R01AG028730NIA NIH HHS R37 AG028730NIDDK NIH HHS DK080836NIDDK NIH HHS R01 DK080836
6 · The paper itself

Abstract

Resveratrol induces mitochondrial biogenesis and protects against metabolic decline, but whether SIRT1 mediates these benefits is the subject of debate. To circumvent the developmental defects of germline SIRT1 knockouts, we have developed an inducible system that permits whole-body deletion of SIRT1 in adult mice. Mice treated with a moderate dose of resveratrol showed increased mitochondrial biogenesis and function, AMPK activation, and increased NAD(+) levels in skeletal muscle, whereas SIRT1 knockouts displayed none of these benefits. A mouse overexpressing SIRT1 mimicked these effects. A high dose of resveratrol activated AMPK in a SIRT1-independent manner, demonstrating that resveratrol dosage is a critical factor. Importantly, at both doses of resveratrol no improvements in mitochondrial function were observed in animals lacking SIRT1. Together these data indicate that SIRT1 plays an essential role in the ability of moderate doses of resveratrol to stimulate AMPK and improve mitochondrial function both in vitro and in vivo.

Indexed as

AMP-Activated Protein Kinase KinasesAnimalsCells, CulturedEnzyme ActivationHepatocytesMiceMice, Inbred C57BLMice, KnockoutMitochondriaMuscle, SkeletalNADProtein KinasesResveratrolSignal TransductionSirtuin 1StilbenesAMP-Activated Protein Kinase KinasesNADProtein KinasesResveratrolSirt1 protein, mouseSirtuin 1Stilbenes

Identifiers

PMID22560220
PMCPMC3545644
OpenAlexW2078575160

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.